SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $798,000 | -14.9% | 33,650 | -1.5% | 0.07% | -14.1% |
| Q3 2019 | $938,000 | -17.0% | 34,150 | 0.0% | 0.08% | -15.0% |
| Q2 2019 | $1,130,000 | -8.3% | 34,150 | -2.8% | 0.10% | -7.4% |
| Q1 2019 | $1,232,000 | -1.2% | 35,150 | -6.4% | 0.11% | -12.2% |
| Q4 2018 | $1,247,000 | -33.7% | 37,550 | +0.5% | 0.12% | -18.0% |
| Q3 2018 | $1,881,000 | -15.8% | 37,350 | 0.0% | 0.15% | -20.6% |
| Q2 2018 | $2,235,000 | +18.3% | 37,350 | -9.5% | 0.19% | +27.7% |
| Q1 2018 | $1,889,000 | +10.9% | 41,250 | -3.5% | 0.15% | +16.5% |
| Q4 2017 | $1,704,000 | -0.4% | 42,750 | 0.0% | 0.13% | -4.5% |
| Q3 2017 | $1,710,000 | -5.6% | 42,750 | +1.7% | 0.13% | -8.3% |
| Q2 2017 | $1,812,000 | +38.3% | 42,050 | +0.5% | 0.14% | +39.4% |
| Q1 2017 | $1,310,000 | +22.8% | 41,850 | -0.9% | 0.10% | +28.4% |
| Q4 2016 | $1,067,000 | -5.6% | 42,250 | -7.5% | 0.08% | +12.5% |
| Q3 2016 | $1,130,000 | +7.5% | 45,700 | -11.4% | 0.07% | +60.0% |
| Q2 2016 | $1,051,000 | – | 51,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |